Browsing by Author "Medeiros, Felipe A."

Now showing 1 - 2 of 2

Augmenting VR/AR Applications with EEG/EOG Monitoring and Oculo-Vestibular Recoupling
(2016-01-01)
Zao, John K.
;
Jung, Tzyy-Ping
;
Chang, Hung-Ming
;
Gan, Tchin-Tze
;
Wang, Yu-Te
Head-mounted virtual reality and augmented reality displays (a. k. a. VR/AR goggles) created a revolutionary multimedia genre that is seeking ever-broadening applications and novel natural human interfaces. Adding neuromonitoring and neurofeedback to this genre is expected to introduce a new dimension to user interaction with the cyber-world. This study presents the development of a Neuromonitoring VR/AR Goggle armed with electroencephalo- gram and electrooculogram sensors, programmable milli-Ampere current stimulators and wireless fog/cloud computing support. Beside of its potential use in mitigating cybersickness, this device may have potential applications in augmented cognition ranging from feedback-controlled perceptual training to on-line learning and virtual social interactions. A prototype of the device has been made from a Samsung Gear VR for S6. This study explains its technical design to ensure precision data sampling, synchronous event marking, real-time signal processing and big data cloud computing support. This study also demonstrates the effective-ness in measuring the event-related potentials during a visual oddball experiment.
Detecting Glaucoma With a Portable Brain-Computer Interface for Objective Assessment of Visual Function Loss
(2017-06-01)
Nakanishi, Masaki
;
Wang, Yu-Te
;
Jung, Tzyy-Ping
;
Zao, John K.
;
Chien, Yu-Yi
IMPORTANCE The current assessment of visual field loss in diseases such as glaucoma is affected by the subjectivity of patient responses and the lack of portability of standard perimeters. OBJECTIVE To describe the development and initial validation of a portable brain-computer interface (BCI) for objectively assessing visual function loss. DESIGN, SETTING, AND PARTICIPANTS This case-control study involved 62 eyes of 33 patients with glaucoma and 30 eyes of 17 healthy participants. Glaucoma was diagnosed based on a masked grading of optic disc stereophotographs. All participants underwent testing with a BCI device and standard automated perimetry (SAP) within 3 months. The BCI device integrates wearable, wireless, dry electroencephalogram and electrooculogram systems and a cellphone-based head-mounted display to enable the detection of multifocal steady state visual-evoked potentials associated with visual field stimulation. The performances of global and sectoral multifocal steady state visual-evoked potentials metrics to discriminate glaucomatous from healthy eyes were compared with global and sectoral SAP parameters. The repeatability of the BCI device measurements was assessed by collecting results of repeated testing in 20 eyes of 10 participants with glaucoma for 3 sessions of measurements separated by weekly intervals. MAIN OUTCOMES AND MEASURES Receiver operating characteristic curves summarizing diagnostic accuracy. Intraclass correlation coefficients and coefficients of variation for assessing repeatability. RESULTS Among the 33 participants with glaucoma, 19 (58%) were white, 12 (36%) were black, and 2 (6%) were Asian, while among the 17 participants with healthy eyes, 9 (53%) were white, 8 (47%) were black, and none were Asian. The receiver operating characteristic curve area for the global BCI multifocal steady state visual-evoked potentials parameter was 0.92 (95% CI, 0.86-0.96), which was larger than for SAP mean deviation (area under the curve, 0.81; 95% CI, 0.72-0.90), SAP mean sensitivity (area under the curve, 0.80; 95% CI, 0.69-0.88; P = .03), and SAP pattern standard deviation (area under the curve, 0.77; 95% CI, 0.66-0.87; P = .01). No statistically significant differences were seen for the sectoral measurements between the BCI and SAP. Intraclass coefficients for global and sectoral parameters ranged from 0.74 to 0.92, and mean coefficients of variation ranged from 3.03% to 7.45%. CONCLUSIONS AND RELEVANCE The BCI device may be useful for assessing the electrical brain responses associated with visual field stimulation. The device discriminated eyes with glaucomatous neuropathy from healthy eyes in a clinically based setting. Further studies should investigate the feasibility of the BCI device for home-based testing as well as for detecting visual function loss over time.